Haemonetics Corporation to Present at the Morgan Stanley Global Healthcare Conference

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BRAINTREE, Mass., Aug. 26, 2013 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that Chris Lindop, CFO & EVP, Business Development, will present at the Morgan Stanley Global Healthcare Conference in New York on September 10th, 2013 at 4:40 pm Eastern time.

(Logo: http://photos.prnewswire.com/prnh/20120206/NE47232LOGO)

The public may access Mr. Lindop’s presentation live via webcast at:
http://cc.talkpoint.com/morg007/090913a_mc/?entity=106_L7ROLD4

About Haemonetics

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative blood management solutions for our customers. Together, our devices and consumables, information technology platforms, and consulting services deliver a suite of business solutions to help our customers improve patient care and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at http://www.haemonetics.com.

CONTACT:
Gerry Gould, VP-Investor Relations
Tel. (781) 356-9402
gerry.gould@haemonetics.com
Alt. (781) 356-9613

SOURCE Haemonetics Corporation

Hey, check out all the research scientist jobs. Post your resume today!

MORE ON THIS TOPIC